Jungang Vaccine Reports Operating Profit of 1.6 Billion KRW in Q1, Up 53% Year-on-Year
[Asia Economy Reporter Minji Lee] Jungang Vaccine announced on the 22nd that its operating profit for the first quarter reached 1.598 billion KRW, a 53% increase compared to the same period last year. Sales amounted to 9.343 billion KRW, up 4% year-on-year. Net profit rose 71% to 1.692 billion KRW.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
